Does pathological response after transarterial chemoembolization for hepatocellular carcinoma in cirrhotic patients with cirrhosis predict outcome after liver resection or transplantation?

Journal of Hepatology

Volumn 63, Issue 1, 2015, Pages 83-92

  Allard, Marc Antoine ^a,b   Sebagh, Mylène ^a,b   Ruiz, Aldrick ^c   Guettier, Catherine ^a,b   Paule, Bernard ^a   Vibert, Eric ^a,b   Cunha, Antonio Sa ^a,b   Cherqui, Daniel ^a,b   Samuel, Didier ^a,b   Bismuth, Henri ^a   Castaing, Denis ^a,b   Adam, René ^a,b  

^a HÔPITAL PAUL BROUSSE   (France)

^b INSERM   (France)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Hepatocellular carcinoma; Liver resection; Liver transplantation; Pathologic response; Transarterial chemoembolization

Indexed keywords

ALPHA FETOPROTEIN; CISPLATIN; DOXORUBICIN; ANTINEOPLASTIC AGENT;

ADULT; ALPHA FETOPROTEIN BLOOD LEVEL; ARTICLE; CANCER PATIENT; CANCER PROGNOSIS; CANCER SURGERY; CANCER SURVIVAL; CHEMOEMBOLIZATION; CONTROLLED STUDY; FEMALE; GRAFT RECIPIENT; HUMAN; INDEPENDENT VARIABLE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER NODULE; LIVER RESECTION; LIVER TRANSPLANTATION; LONG TERM SURVIVAL; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OVERALL SURVIVAL; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RECURRENCE FREE SURVIVAL; REFERENCE VALUE; RETROSPECTIVE STUDY; SURVIVAL RATE; TREATMENT OUTCOME; TREATMENT RESPONSE; TUMOR VOLUME; CARCINOMA, HEPATOCELLULAR; COMPLICATION; FOLLOW UP; INTRAARTERIAL DRUG ADMINISTRATION; LIVER NEOPLASMS; PROCEDURES; PROGNOSIS;

ANTINEOPLASTIC AGENTS; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; FEMALE; FOLLOW-UP STUDIES; HEPATECTOMY; HUMANS; INJECTIONS, INTRA-ARTERIAL; LIVER CIRRHOSIS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84931575704     PISSN: 01688278     EISSN: 16000641     Source Type: Journal    
DOI: 10.1016/j.jhep.2015.01.023     Document Type: Article

References (34)

1. Y. Tanaka, K. Hanada, M. Mizokami, A.E. Yeo, J.W. Shih, and T. Gojobori A comparison of the molecular clock of hepatitis C virus in the United States and Japan predicts that hepatocellular carcinoma incidence in the United States will increase over the next two decades Proc Natl Acad Sci U S A 99 2002 15584 15589
2. V. Mazzaferro, E. Regalia, R. Doci, S. Andreola, A. Pulvirenti, and F. Bozzetti Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis N Engl J Med 334 1996 693 699
3. T. Ishizawa, K. Hasegawa, T. Aoki, M. Takahashi, Y. Inoue, and K. Sano Neither multiple tumors nor portal hypertension are surgical contraindications for hepatocellular carcinoma Gastroenterology 134 2008 1908 1916
4. J.P. Duffy, A. Vardanian, E. Benjamin, M. Watson, D.G. Farmer, and R.M. Ghobrial Liver transplantation criteria for hepatocellular carcinoma should be expanded: a 22-year experience with 467 patients at UCLA Ann Surg 246 2007 502 509 discussion 509-511
5. G. Ercolani, G.L. Grazi, M. Ravaioli, M. Del Gaudio, A. Gardini, and M. Cescon Liver resection for hepatocellular carcinoma on cirrhosis: univariate and multivariate analysis of risk factors for intrahepatic recurrence Ann Surg 237 2003 536 543
6. W.P. Zhou, E.C. Lai, A.J. Li, S.Y. Fu, J.P. Zhou, and Z.Y. Pan A prospective, randomized, controlled trial of preoperative transarterial chemoembolization for resectable large hepatocellular carcinoma Ann Surg 249 2009 195 202
7. W.C. Chapman, M.B. Majella Doyle, J.E. Stuart, N. Vachharajani, J.S. Crippin, and C.D. Anderson Outcomes of neoadjuvant transarterial chemoembolization to downstage hepatocellular carcinoma before liver transplantation Ann Surg 248 2008 617 625
8. G.C. Sotiropoulos, M. Malago, E.P. Molmenti, A. Radtke, E.I. Brokalaki, and S. Nadalin Disease course after liver transplantation for hepatocellular carcinoma in patients with complete tumor necrosis in liver explants after performance of bridging treatments Eur J Med Res 10 2005 539 542
9. P.E. Majno, R. Adam, H. Bismuth, D. Castaing, A. Ariche, and J. Krissat Influence of preoperative transarterial lipiodol chemoembolization on resection and transplantation for hepatocellular carcinoma in patients with cirrhosis Ann Surg 226 1997 688 701 discussion 701-683
10. D.G. Blazer 3rd, Y. Kishi, D.M. Maru, S. Kopetz, Y.S. Chun, and M.J. Overman Pathologic response to preoperative chemotherapy: a new outcome end point after resection of hepatic colorectal metastases J Clin Oncol 26 2008 5344 5351
11. R. Adam, D.A. Wicherts, R.J. de Haas, T. Aloia, F. Levi, and B. Paule Complete pathologic response after preoperative chemotherapy for colorectal liver metastases: myth or reality? J Clin Oncol 26 2008 1635 1641
12. L.J. Esserman, D.A. Berry, A. DeMichele, L. Carey, S.E. Davis, and M. Buxton Pathologic complete response predicts recurrence-free survival more effectively by cancer subset: results from the I-SPY 1 TRIAL-CALGB 150007/150012, ACRIN 6657 J Clin Oncol 30 2012 3242 3249
13. S.G. Yeo, D.Y. Kim, T.H. Kim, H.J. Chang, J.H. Oh, and W. Park Pathologic complete response of primary tumor following preoperative chemoradiotherapy for locally advanced rectal cancer: long-term outcomes and prognostic significance of pathologic nodal status (KROG 09-01) Ann Surg 252 2010 998 1004
14. J. Bruix, M. Sherman, J.M. Llovet, M. Beaugrand, R. Lencioni, and A.K. Burroughs Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver J Hepatol 35 2001 421 430
15. P. Majno, E. Giostra, P. Morel, A. Hadengue, and G. Mentha Management of hepatocellular carcinoma in the waiting list before liver transplantation J Hepatol 42 2005 S134 S143
16. R. Adam, P. Bhangui, E. Vibert, D. Azoulay, G. Pelletier, and J.C. Duclos-Vallee Resection or transplantation for early hepatocellular carcinoma in a cirrhotic liver: does size define the best oncological strategy? Ann Surg 256 2013 883 891
17. P.A. Clavien, M. Lesurtel, P.M. Bossuyt, G.J. Gores, B. Langer, and A. Perrier Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report Lancet Oncol 13 2012 e11 e22
18. K. Boudjema Third consensus conference on liver transplantation. Lyon, France, 19 and 20 January 2005 Bull Acad Natl Med 191 2007 1627 1638 1640; discussion 1638-1639
19. J.M. Llovet, A.M. Di Bisceglie, J. Bruix, B.S. Kramer, R. Lencioni, and A.X. Zhu Design and endpoints of clinical trials in hepatocellular carcinoma J Natl Cancer Inst 100 2008 698 711
20. S.B.B.D. Edge, C.C. Compton, A.G. Fritz, F.L. Greene, and A. Trotti American joint committee on cancer staging manual 7th ed. 2010 Springer New York
21. R. Golfieri, A. Cappelli, A. Cucchetti, F. Piscaglia, M. Carpenzano, and E. Peri Efficacy of selective transarterial chemoembolization in inducing tumor necrosis in small (<5 cm) hepatocellular carcinomas Hepatology 53 2011 1580 1589
22. I.W. Graziadei, H. Sandmueller, P. Waldenberger, A. Koenigsrainer, K. Nachbaur, and W. Jaschke Chemoembolization followed by liver transplantation for hepatocellular carcinoma impedes tumor progression while on the waiting list and leads to excellent outcome Liver Transpl 9 2003 557 563
23. T. Higuchi, M. Kikuchi, and M. Okazaki Hepatocellular carcinoma after transcatheter hepatic arterial embolization. A histopathologic study of 84 resected cases Cancer 73 1994 2259 2267
24. S.W. Kwan, N. Fidelman, E. Ma, R.K. Kerlan Jr., and F.Y. Yao Imaging predictors of the response to transarterial chemoembolization in patients with hepatocellular carcinoma: a radiological-pathological correlation Liver Transpl 18 2012 727 736
25. M. Ravaioli, G.L. Grazi, G. Ercolani, M. Fiorentino, M. Cescon, and R. Golfieri Partial necrosis on hepatocellular carcinoma nodules facilitates tumor recurrence after liver transplantation Transplantation 78 2004 1780 1786
26. G. Otto, M. Schuchmann, M. Hoppe-Lotichius, M. Heise, A. Weinmann, and T. Hansen How to decide about liver transplantation in patients with hepatocellular carcinoma: size and number of lesions or response to TACE? J Hepatol 59 2013 279 284
27. I. Bargellini, C. Vignali, R. Cioni, P. Petruzzi, A. Cicorelli, and D. Campani Hepatocellular carcinoma: CT for tumor response after transarterial chemoembolization in patients exceeding Milan criteria-selection parameter for liver transplantation Radiology 255 2010 289 300
28. T. Imaeda, Y. Yamawaki, M. Seki, H. Goto, G. Iinuma, and M. Kanematsu Lipiodol retention and massive necrosis after lipiodol-chemoembolization of hepatocellular carcinoma: correlation between computed tomography and histopathology Cardiovasc Intervent Radiol 16 1993 209 213
29. Y.K. Cho, J.K. Kim, M.Y. Kim, H. Rhim, and J.K. Han Systematic review of randomized trials for hepatocellular carcinoma treated with percutaneous ablation therapies Hepatology 49 2009 453 459
30. G. N'Kontchou, A. Mahamoudi, M. Aout, N. Ganne-Carrie, V. Grando, and E. Coderc Radiofrequency ablation of hepatocellular carcinoma: long-term results and prognostic factors in 235 Western patients with cirrhosis Hepatology 50 2009 1475 1483
31. J.M. Llovet, S. Ricci, V. Mazzaferro, P. Hilgard, E. Gane, and J.F. Blanc Sorafenib in advanced hepatocellular carcinoma N Engl J Med 359 2008 378 390
32. A.L. Cheng, Y.K. Kang, Z. Chen, C.J. Tsao, S. Qin, and J.S. Kim Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial Lancet Oncol 10 2009 25 34
33. S. Irtan, X. Chopin-Laly, M. Ronot, S. Faivre, V. Paradis, and J. Belghiti Complete regression of locally advanced hepatocellular carcinoma induced by sorafenib allowing curative resection Liver Int 31 2011 740 743
34. A.M. El-Badry, S. Breitenstein, W. Jochum, K. Washington, V. Paradis, and L. Rubbia-Brandt Assessment of hepatic steatosis by expert pathologists: the end of a gold standard Ann Surg 250 2009 691 697